Pharmacolog i Uppsala AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 - Marketscreener.com
| P750 Stock | 0.55 0.04 6.78% |
Roughly 62% of PHARMACOLOG's investor base is looking to short. The analysis of current outlook of investing in PHARMACOLOG I UPPSALA suggests that many traders are alarmed regarding PHARMACOLOG's prospects. The current market sentiment, together with PHARMACOLOG's historical and current headlines, can help investors time the market. In addition, many technical investors use PHARMACOLOG I UPPSALA stock news signals to limit their universe of possible portfolio assets.
PHARMACOLOG stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of PHARMACOLOG daily returns and investor perception about the current price of PHARMACOLOG I UPPSALA as well as its diversification or hedging effects on your existing portfolios.
PHARMACOLOG |
Pharmacolog i Uppsala AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 Marketscreener.com
Read at news.google.com
 |
PHARMACOLOG I UPPSALA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PHARMACOLOG stock to make a market-neutral strategy. Peer analysis of PHARMACOLOG could also be used in its relative valuation, which is a method of valuing PHARMACOLOG by comparing valuation metrics with similar companies.
Peers
PHARMACOLOG Related Equities
| TSFA | Taiwan Semiconductor | 1.45 | ||||
| RKET | Rocket Internet | 1.28 | ||||
| ELG | Elmos Semiconductor | 1.00 | ||||
| SMG | Magnachip Semiconductor | 0.52 | ||||
| BAC | Bank of America | 0.29 | ||||
| CAC1 | Casio Computer | 0.25 | ||||
| 1CG | CRISPR Therapeutics | 0.00 | ||||
| CQD | Charter Communications | 3.52 |
Complementary Tools for PHARMACOLOG Stock analysis
When running PHARMACOLOG's price analysis, check to measure PHARMACOLOG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMACOLOG is operating at the current time. Most of PHARMACOLOG's value examination focuses on studying past and present price action to predict the probability of PHARMACOLOG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PHARMACOLOG's price. Additionally, you may evaluate how the addition of PHARMACOLOG to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |